Navigation Menu

Clinical Trial External Search

Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Craig Meyers, MS, PhD

Craig Meyers, MS, PhD

Distinguished Professor, Department of Microbiology and Immunology
Distinguished Professor, Department of Obstetrics and Gynecology
Scientific Program:Mechanisms of Carcinogenesis

Research Interests

Presently, the central research goals of Dr. Craig Meyers' laboratory are to study the differentiation-dependent life cycle of human papillomavirus (HPV) and HPV-associated oncogenesis. Studies in the Meyers lab follow five general research themes:

  • Investigation of the molecular biology and genetics of HPV morphogenesis and structure in native virus replicated under natural physiological differentiation conditions of the host tissue. The majority of the laboratories studying HPV morphogenesis and structure utilize synthetic particles such as virus-like particles (VLPs) or pseudoviral particles (PsV). The Meyers lab's studies have shown that the morphogenesis, maturation, and structure of native HPV differs in many significant characteristic from VLPs or PsV particles. 
  • Developing an understanding of ethnic differences in HPV types and variants using a whole-genome analysis, including infection prevalence and carcinogenicity. 
  • Investigating the epigenetic mechanisms of HPV-associated oral disease. This will be done by measuring genome-wide epigenetic changes occurring at different stages of the HPV16 life cycle, carcinogenic progression, and in response to ART treatment. Determining the interaction of highly active anti-retroviral drugs on oral tissues, HPV and HPV’s infection of oral tissue. 
  • Comparative analysis of HPV infection, life cycle and oncogenesis at different anatomical sites, including the cervix, foreskin, tonsil and anal canal. 
  • In addition to HPV, Dr. Meyers is also interested in studying the life cycle of other epitheliotropic infectious agents, such as the Herpes virus family, in three-dimensional human epithelial tissue.
  • Keratinocytes
  • Virion
  • Epithelium
  • Human papillomavirus 16
  • Life Cycle Stages
  • Viruses
  • Infections
  • DNA
  • Neoplasms
  • Uterine Cervical Neoplasms
  • Genes
  • Growth

Recent Publications


Izaguirre, G, Phan, LMU, Asif, S, Alam, S, Meyers, C & Rong, L 2024, 'Diversity in Proprotein Convertase Reactivity among Human Papillomavirus Types', Viruses, vol. 16, no. 1, 39.


Hayman, IR, Temple, RM, Burgess, CK, Ferguson, M, Liao, J, Meyers, C & Sample, CE 2023, 'New insight into Epstein-Barr virus infection using models of stratified epithelium', PLoS pathogens, vol. 19, no. 1, e1011040.
Walston, JJ, Hayman, IR, Gore, M, Ferguson, M, Temple, RM, Liao, J, Alam, S, Meyers, C, Tugizov, SM, Hutt-Fletcher, L & Sample, CE 2023, 'The Epstein-Barr Virus Glycoprotein BDLF2 Is Essential for Efficient Viral Spread in Stratified Epithelium', Journal of virology, vol. 97, no. 2.


Tucker, J, Milici, J, Alam, S, Ferster, APOC, Goldenberg, D, Meyers, C & Goyal, N 2022, 'Assessing nonsexual transmission of the human papillomavirus (HPV): Do our current cleaning methods work?', Journal of Medical Virology, vol. 94, no. 8, pp. 3956-3961.
Robins, LI, Clark, A, Gafken, PR, Alam, S, Milici, J, Hassan, R, Wang, CY, Williams, J & Meyers, C 2022, 'Hypochlorous acid as a disinfectant for high-risk HPV: Insight into the mechanism of action', Journal of Medical Virology, vol. 94, no. 7, pp. 3386-3393.


Brendle, S, Cladel, N, Balogh, K, Alam, S, Christensen, N, Meyers, C & Hu, J 2021, 'A comparative study on delivery of externally attached dna by papillomavirus vlps and pseudoviruses', Vaccines, vol. 9, no. 12, 1501.
Meyers, C, Kass, R, Goldenberg, D, Milici, J, Alam, S & Robison, R 2021, 'Ethanol and isopropanol inactivation of human coronavirus on hard surfaces', Journal of Hospital Infection, vol. 107, pp. 45-49.
Carvalho, J, Lopes-Nunes, J, Campello, MPC, Paulo, A, Milici, J, Meyers, C, Mergny, JL, Salgado, GF, Queiroz, JA & Cruz, C 2021, 'Human Papillomavirus G-Rich Regions as Potential Antiviral Drug Targets', Nucleic Acid Therapeutics, vol. 31, no. 1, pp. 68-81.
Liu, H, Xu, J, Yang, Y, Wang, X, Wu, E, Majerciak, V, Zhang, T, Steenbergen, RDM, Wang, HK, Banerjee, NS, Li, Y, Lu, W, Meyers, C, Zhu, J, Xie, X, Chow, LT & Zheng, ZM 2021, 'Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1', Proceedings of the National Academy of Sciences of the United States of America, vol. 118, no. 3, e2014195118.


Babaev, M, Khusnutdinova, E, Lobov, A, Galimova, Z, Petrova, A, Rybalova, T, Nguyen, HTT, Meyers, C, Prichard, M & Kazakova, O 2022, 'Allobetulone rearrangement to l8αH,19βH-ursane triterpenoids with antiviral activity', Natural Product Research, vol. 36, no. 13, pp. 3286-3296.
Alam, S, Chatterjee, S, Kang, SD, Milici, J, Biryukov, J, Chen, H & Meyers, C 2020, 'Anti-retroviral protease inhibitors regulate human papillomavirus 16 infection of primary oral and cervical epithelium', Cancers, vol. 12, no. 9, 2664, pp. 1-34.
Meyers, C, Miller, J & Robinson, R 2020, 'Die Fähigkeit von zwei Chlordioxid-Produkten, Humane Papillomaviren auf endokavitären Ultraschallsonden und Nasopharyngoskopen zu inaktivieren', Hygiene + Medizin, vol. 45, no. 10, pp. D129-D133.
Meyers, C, Robison, R, Milici, J, Alam, S, Quillen, D, Goldenberg, D & Kass, R 2021, 'Lowering the transmission and spread of human coronavirus', Journal of Medical Virology, vol. 93, no. 3, pp. 1605-1612.
Meyers, C, Robison, R, Milici, J, Alam, S, Quillen, D, Goldenberg, D & Kass, R 2021, 'Rebuttal to overinterpretation of the antiviral results for human coronavirus 229E relative to severe acute respiratory syndrome coronavirus-2 by Rowpar Pharmaceuticals', Journal of Medical Virology, vol. 93, no. 4, pp. 1903-1904.
Meyers, C, Milici, J & Robison, R 2020, 'The ability of two chlorine dioxide chemistries to inactivate human papillomavirus-contaminated endocavitary ultrasound probes and nasendoscopes', Journal of Medical Virology, vol. 92, no. 8, pp. 1298-1302.